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Objective: Patients with factitious disorder (FD) fabricate illness, injury or impairment for psychological reasons
and, as a result, misapply medical resources. The demographic and clinical proﬁle of these patients has yet to be
described in a sufﬁciently large sample, which has prevented clinicians from adopting an evidence-based ap-
proach to FD. The present study aimed to address this issue through a systematic review of cases reported in
the professional literature.
Method: A systematic search for case studies in the MEDLINE, Web of Science and EMBASE databases was con-
ducted. A total of 4092 recordswere screened and 684 remaining paperswere reviewed. A supplementary search
was conducted via GoogleScholar, reference lists of eligible articles and key review papers. In total, 372 eligible
studies yielded a sample of 455 cases. Information extracted included age, gender, reported occupation, comorbid
psychopathology, presenting signs and symptoms, severity and factors leading to the diagnosis of FD.
Results: A total of 66.2% of patients in our sample were female. Mean age at presentation was 34.2 years. A
healthcare or laboratory profession was reported most frequently (N=122). A current or past diagnosis of de-
pression was described more frequently than personality disorder in cases reporting psychiatric comorbidity
(41.8% versus 16.5%) and more patients elected to self-induce illness or injury (58.7%) than simulate or falsely
report it. Patients were most likely to present with endocrinological, cardiological and dermatological problems.
Differences among specialties were observed on demographic factors, severity and factors leading to diagnosis
of FD.
Conclusions: Based on the largest sample of patientswith FD analyzed to date, our ﬁndings offer an importantﬁrst
step toward an evidence-based approach to the disorder. Future guidelines must be sensitive to differing
methods used by specialists when diagnosing FD.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Factitious disorder (FD)with physical symptoms is a psychiatric dis-
order in which sufferers intentionally fabricate illness, injury or impair-
ment in order to gain hospital admission and undergo medical
procedures, without any obvious gain [1]. It is considered to be one of
the most challenging disorders in medical experience [2]. Patients
with FD may exaggerate or lie about a medical condition, mimic or
“act out” medical symptoms, interfere with diagnostic investigations
or even directly self-induce illness or injury [3]. In contrast to malin-
gerers, who fabricate medical need for reasons of clear external reward
(such as evading military service or gaining disability beneﬁts), thess for this article was funded by
o other funding sources and no
titute of Psychiatry, Psychology
.: +44-7805-3404-79.
. This is an open access article undermotivations of patients with FD are ‘almost always obscure’ [4] and
may include a desire to receive affection and care, an “adrenaline
rush” from undergoing medical procedures or a sense of control from
deceiving healthcare professionals [5]. Patients with FD may expose
themselves to a considerable risk of iatrogenic harm [6]. Indeed, one pa-
tient with FD described by Robertson and Hossain [7] admitted to hav-
ing undergone 42 surgical procedures over the course of 850 admissions
to 650 different hospitals. Fatality due to FD appears to be rare, but it
does occur [8–11].
Studies on FD demonstrate the heavy impact of unnecessary investi-
gations, treatments and hospital admissions on the healthcare system.
Healthcare costs in individual cases of FD have exceeded $200,000
[12] and even $1,000,000 [13]. A patient with FD may also have a con-
siderable psychological impact on hospital staff involved in their care.
Staff may feel anger at having been “duped” by the patient and
“cheated” of the time and support they have expended [14,15], or
they may experience guilt for allowing themselves to be drawn into
the emotional conﬂicts that frequently arise in cases of FD [16,17].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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course of their clinical practice [18]. However, the exact prevalence of
FD in hospital settings is currently unknown [19–21]. FD may account
for between 0.6% and 3% of referrals from general medicine to psychia-
try [22–24] and between 0.02% and 0.9% of cases reviewed in specialist
clinics [25–28]. A recent study surveying physicians' own estimates of
the presence of factitious symptoms among their patients reported a
higher prevalence rate of 1.3% [29]. Rates of FDmay be greatly increased
in patient populationswhose reportedproblems are diagnostically chal-
lenging [30,31] or have received signiﬁcant public attention [32].
Although FDhas been recognized by clinicians for centuries [33], if not
millennia [34], theﬁrst extensive studyon FDappears inAsher's initial de-
scription of “Munchausen's syndrome” in 1951. However, since that time,
the term “Munchausen's syndrome” has become a source of confusion in
both clinical practice and the published literature [3]. The correct usage of
the term is to denote a particularly severe and chronic presentation of FD
[33], but “Munchausen's” is often used interchangeably with “factitious”.
Other terms used for FD include “hospital hopper syndrome”, “hospital
hobo syndrome” and “thick chart syndrome”, and they frequently display
a level of irony — e.g. “black hole patients” or “peregrinating problem
patients”. These terms reﬂect that patients with FD can be derided by
healthcare professionals.
Patientswith FDmay fabricatemedical need in severalways. The va-
riety of methods available to these patients is limited in principle only
by their level of dedication, imagination and medical knowledge [35]
but is dependent in practice upon the nature of the medical problem
they intend to fabricate. For example, a patient with FD attempting to
fabricate urological disease may falsely report the presence of chronic
urinary discomfort, deliberatelywithhold urine to simulate acute anuria
[36], add blood to urine samples to simulate hematuria [37] or actually
induce a urinary tract infection by self-injection with bacterial cultures
[38]. A patient attempting to fabricate a dermatological condition may
be restricted to simulating a lesion (e.g. by discoloration of the skin
with ink [39]) or creating an actual lesion through self-mutiliation
[40] or other means [41]. Patients with FD may employ several of
these methods at once [3] and frequently present with diverse symp-
tomatology. The wealth of medical knowledge now available on the In-
ternet may enable patients lacking a background in healthcare to
present with complex medical problems. It is seldom possible to diag-
nose FD with conviction [3] but when the diagnosis is made, it usually
follows an exhaustive series of medical procedures undertaken to rule
out an organic explanation for the patient's problems.
Early detection of FD is thus paramount in order to limit wastage of
healthcare resources and harm to patients. Early management of FD
may also facilitate improved outcomes for patients with the disorder
[3]. However, the clinical and demographic proﬁle of patients with FD
has not been clariﬁed with a sufﬁciently large sample [33]. We consider
such knowledge to be an important ﬁrst step in the development of an
evidence-based approach to the early detection and management of FD
in clinical settings. The majority of the published literature on FD con-
sists of case reports and series, which are a valuable source of informa-
tion but may present a misleading clinical picture of the disorder in
isolation [42]. Indeed, assumptions about the characteristics of patients
with FD abound in the professional literature — one troubling example
being the idea that the majority of patients with the disorder are male,
as speciﬁed in the DSM-IV despite the clear lack of research supporting
such a statement [43]. Although recommendations have been published
concerning the detection of FD (e.g. see Ref. [33]), these recommenda-
tions have not been supported by broad evidence on how FD is diag-
nosed by clinicians on a wider scale or how methods for detecting
medical deception may vary among medical specialties. Similarly,
guidelines for management of FD (e.g. see Ref. [44]) have been written
in the absence of substantial data concerning the severity of the
methods typically adopted by patients with FD— or indeed the suicide
risk and psychiatric comorbidity associatedwith the disorder. This is in-
formation integral to effective management of FD [17].What is therefore needed is a comprehensive and systematic review
of the case reports and series available in the professional literature, as
has been undertaken previously with child and adolescent FD [45],
FD imposed upon another or “Munchausen-by-proxy syndrome” [46–48]
and other uncommon disorders [49–51]. Use of this method has
enabled authors to examine the clinical and demographic characteristics
of samples of patients larger than would be feasible for comparable
empirical studies.
Unfortunately, only a limited number of reviews have been pub-
lished on FD, and those published to date have been mainly limited to
a small number of cases from single medical specialties— recently, car-
diology [32], neurology [52], obstetrics and gynecology [53], ENT [54],
oncology [55] and dermatology [56]. Authors who have aggregated
cases across specialties have limited their sample to cases of FD that
have been treated [57] or detected by laboratory testing [58-60], and
they have therefore analyzed only a minority of cases available in the
professional literature.
Thus, itwas the aim of this study to undertake a comprehensive, sys-
tematic review of all cases of FD with physical symptoms published in
the professional literature to date, to characterize for the ﬁrst time the
basic demographic and clinical proﬁle of patientswith FD in a large sam-
ple and to compare these features among medical specialties. This re-
view was restricted to adult cases of FD, as a full review of child and
adolescent FD was beyond the scope of this study and has previously
been conducted [45].2. Method
2.1. Types of study
A systematic search was conducted for all case studies and series
that reported on adult patients eligible for a DSM-5 diagnosis of FD
with primarily physical symptoms [1] on the basis of the clinical infor-
mation provided by the author(s). This search included cases where
the diagnosis of FD was described in other terms, such as ‘dermatitis
artefacta’ and ‘Munchausen's’, or was classiﬁed according to a compara-
ble diagnostic system, such as DSM-IV [43] or ICD-10 [4]. Chart reviews
and larger case series were excluded if they did not also describe cases
individually. Following the conservative methodology outlined by
Kanaan and Wessely [52], studies were excluded if they reported
cases in which no ﬁrm diagnosis of FD could be made.2.2. Search strategy
A broad keyword search of literature published in English between
January 1, 1965 and July 27, 2015was conducted. MEDLINE,Web of Sci-
ence and EMBASE databases were searched using the terms, factit*,
munchausen*, artefacta* and artefactua*. Recordswith ‘by proxy’ or ‘im-
posed upon another’ were not automatically ﬁltered out of the search
results in order to ensure that case series reporting both FD and FD im-
posed upon another were included. A total of 4256 records were
returned following exclusion of duplicate records, of which 4092 were
retrieved for abstract review. A total of 748 records were identiﬁed as
potentially eligible, of which 684 were retrieved for full-text review. A
total of 333 studies were selected for inclusion after full-text review.
The bibliographies of eligible studies were also screened, in addition to
the bibliographies of multiple review papers [52–59] and the results
of a GoogleScholar search utilizing terms identical to the keyword
search. These supplementary searchprocesses yielded a further 39 eligi-
ble studies. Search formulae for MEDLINE, Web of Science and EMBASE
databases are provided in Section 1 of the supplemental material. The
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) ﬂow chart for the search process is provided in Section 2 of
the supplemental material.
Table 1
Factors leading to diagnosis of FD
# Factor Examples
1 Past healthcare
service use
History of extensive healthcare service use; history of
peregrination between healthcare services; history of
FD conﬁrmed by healthcare professional
2 Information provided
by patient
Inconsistent, selective or misleading biographical
information provided; evasive when history is taken;
dramatic but unlikely medical history provided;
unusual difﬁculty corroborating information
provided; refusal to allow access to outside
information sources
3 Atypical presentation Symptoms predominantly occur when the patient is
not under observation; course of illness is impossible,
highly improbable or does not follow the natural
history of the presumed diagnosis
4 Unsubstantiated
presentation
Investigations normal or inconclusive
5 Evidence of
fabrication
Physical evidence of fabrication discovered through
search or surveillance; patient directly witnessed
simulating disease
6 Patient behavior Unusual medical knowledge or use of medical
terminology; eagerness for medical procedures;
aggression or defensiveness with healthcare staff;
noncompliance with diagnostic or treatment
recommendations; pseudologia fantastica; patient
opposes psychiatric involvement while pursuing
medical or surgical options
7 Investigations
indicating fabrication
Investigations reveal mechanism of fabrication;
investigations rule out organic etiology; evidence
from investigations contradicts information provided
by patient
8 Treatment failure Appearance of new symptoms on commencement of
treatment; symptoms worsen on commencement of
treatment
Table 2
Basic demographic characteristics of patients diagnosed with FD by medical specialty
Specialty N Age (SD; range [min; max]) % Female
Allergy and Immunology 8 27.9 (10.3; 31 [min 20; max 51]) 88
Cardiology 44 38.4 (11.9; 47 [min 20; max 67]) 23
Dermatology 43 40.6 (16; 61 [min 18; max 79]) 79
Endocrinology 59 32.3 (9.4; 36 [min 18; max 54]) 78
ENT 11 28.3 (10.9; 37 [min 19; max 56]) 73
Gastroenterology 29 34.1 (11; 43 [min 19; max 62]) 76
Hematology 27 34.4 (14.4; 53 [min 21; max 74]) 74
HIV and Sexual Health 11 32 (12; 43 [min 19; max 62]) 45
Microbiology and Infection 13 28.5 (6.3; 25 [min 18; max 43]) 92
Neurology 32 34.4 (10; 46 [min 22; max 68]) 44
Obstetrics and Gynecology 7 40.3 (16.1; 47 [min 21; max 68]) 100
Oncology 12 31.6 (7.9; 26 [min 19; max 45]) 92
Ophthalmology 18 32.1 (15.2; 55 [min 18; max 73]) 83
Oral and Maxillofacial 8 27.4 (5.3; 15 [min 20; max 35]) 75
Orthopedics and Trauma 34 30.1 (9.9; 38 [min 18; max 56]) 53
Plastic and Reconstructive Surgery 13 33.4 (9.4; 31 [min 23; max 54]) 77
Pulmonary and Respiratory 33 33 (12.8; 53 [min 19; max 72]) 70
Rheumatology 9 36.9 (8.2; 25 [min 22; max 47]) 67
Urology and Nephrology 30 34.9 (9.9; 35 [min 22; max 57]) 53
Other 14 41.7 (8.5; 31 [min 22; max 53]) 71
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Amean number of 9.1 new cases per year was reported over the re-
view period, with a tendency toward higher values in more recent
years: 1965–1975 (3.5/year), 1975–1985 (7.4/year), 1985–1995 (11.2/
year), 1995–2005 (12/year) and 2005–2015 (11.3/year). Single cases
were extracted from 86% of studies, while the remaining 14% contribut-
ed multiple patients.
The following quantitative and qualitative variables were obtained
(percentage of data found indicated in parentheses) for each case: age
(99%), gender (100%), reported occupation (47%), index presentation of
FD (100%), psychopathology (37%) and factors leading to diagnosis of FD
(100%). When recording reported occupation, patients were only coded
as ‘unemployed’ when this was speciﬁed by authors. Similarly, a lack
of mention of patient psychopathology was not interpreted as an ab-
sence of comorbid psychiatric symptomatology, which was only coded
when authors clearly speciﬁed that a psychiatric assessment or chart re-
view had taken place with nothing of signiﬁcance found. Marital status,
race and ethnicity and educationwere reported only in a small minority
of cases and were therefore not addressed in this review.
Presentation of FDwas extracted by recording the presenting sign(s),
symptom(s) or diagnosis at admission. Each presentation was recorded
as ‘falsely reported’, ‘feigned’ or ‘induced’ according to clinical informa-
tion provided and categorized bymedical specialty according to system
affected and initial referral. Following Kanaan and Wessely [61], where
a history of repeat presentationswas described, initial presentationwas
taken to be the index presentation for the case.
Psychopathologywas extracted by recording current or historic psy-
chiatric diagnoses described by the author(s). Diagnoses were not re-
corded where there was signiﬁcant doubt expressed by the
author(s) concerning the veracity of psychiatric symptoms described.
Factors leading to diagnosis of FD were extracted using a checklist
adapted from two surveys of clinical information thatmight raise suspi-
cion of FD [33,44]. This checklist included 8 items outlined with exam-
ples in Table 1. Items on the checklist were coded only if the factor
contributed to the diagnosismade by the author(s). Clinical information
that did not contribute to the diagnosis made by the author(s), or con-
tributed in retrospect only, was not assessed.
2.4. Analysis
IBM SPSS 23 [62]was used to calculate descriptive statistics. A narra-
tive synthesis was undertaken to describe common presentations and
fabrication methods reported by included studies.
3. Results
3.1. Demographics
Patients with FD were described worldwide: 249 from America
(United States of America, 237; Canada, 8; Brazil, 2), 150 from Europe
(United Kingdom, 94; Italy, 9; Germany, 8; Belgium, 7; Greece, 6; the
Netherlands, 6; Poland, 4; Republic of Ireland, 3; Austria, 2; Croatia, 2;
Denmark, 2; Spain, 2; France, 1; Hungary, 1; Macedonia, 1; Sweden, 1;
Romania, 1), 5 from Africa (Tunisia, 2; Morocco, 1; South Africa, 1;
Zimbabwe, 1), 42 from Asia (Japan, 13; Turkey, 13; India, 6; Saudi
Arabia, 4; Israel, 3; Iran, 3), 7 from Australia, 1 from New Zealand and
1 from Cuba.
A total of 33.8% of patients with FD were male. Mean age at presen-
tationwas 34.2 years with amedian of 32 years and a range of 61 (max-
imum, 79; minimum, 18). Table 2 contains a breakdown of age and
gender by medical specialty. Patient occupation was described in 214
(47%) cases. In 122 of these cases, a healthcare/laboratory profession
was reported. The singlemost common occupation describedwas nurs-
ing (N=68),3.2. Index presentation of FD
Table 3 contains a summary of presentations of FD by medical spe-
cialty. A narrative synthesis describing common presentations and fab-
rication methods reported by included studies is provided in Section 3
of the supplementalmaterial. Across all specialties, 22.2% falsely report-
ed disease/injury, 19.1% simulated disease/injury and 58.7% induced
disease/injury. A full breakdown of FD severity by medical specialty is
included in Table 4.
Table 3
Index presentations of cases by medical specialty
Specialty N Index presentations
Allergy and Immunology 8 Allergic emergency induced (N=3), signs of immune deﬁciency induced (N=3), allergic emergency simulated (N=2)
Cardiology 44 Retrosternal chest pain reported (N=29), hypertension induced (N=5), arrhythmia induced (N=2), unconsciousness and
bradycardia induced (N=1), history of myocardial infarction reported (N=1), syncopal episodes simulated (N=3), syncopal episodes
induced (N=1), history of syncopal episodes reported (N=1), ventricular tachycardia and myocardial infarction induced (N=1)
Dermatology 43 Generalized lesions induced (N=10), breast lesions induced (N=7), facial lesions induced (N=4), leg lesions induced (N=3),
pyoderma gangrenosum simulated (N=3), pyoderma gangrenosum induced (N=1), hand lesions induced (N=2), genital lesions
induced (N=2), purpura of the knee induced (N=2), subcutaneous nodules and abscesses induced (N=2), ulceration of elbow and
forearm induced (N=1), acute erythematous eruption induced (N=2), neck lesions induced (N=1), arm lesions induced (N=1),
generalized purulent lesions with licheniﬁcation induced (N=1), swelling of the hand induced (N=1), painful lobules of lower body
induced (N=1), cheilorrhagia and cheilitis of lip induced (N=1)
Endocrinology 59 Recurrent hypoglycemia induced (N=31), signs and symptoms of Cushing's syndrome induced (N=9), thyrotoxicosis induced (N=8),
diabetic ketoacidosis induced (N=4), history of diabetes reported (N=2), hyperglycemia induced (N=1), pheochromocytoma
simulated (N=1), endocrine neoplasia simulated (N=1), symptoms and family history of multiple endocrine neoplasia reported
(N=1), history of Zollinger-Ellison syndrome reported (N=1)
ENT 11 Facial swelling induced (N=4), airway distress reported (N=2), bleeding from mouth, nose, ears and eyes simulated (N=1), bleeding
from ears simulated (N=1), airway distress feigned (N=1), cheilitis of lip induced (N=1), ear drainage simulated (N=1)
Gastroenterology 29 Severe diarrhea induced (N=6), diarrhea simulated (N=2), recurrent vomiting induced (N=1), hematemesis simulated (N=5),
hematemesis and hematochezia reported (N=1), hematemesis induced (N=1), gastrointestinal bleeding induced (N=3), epigastric
pain induced (N=3), rectal bleeding simulated (N=1), gastrointestinal bleeding simulated (N=1), deterioration of Crohn's disease
induced (N=2), urointestinal ﬁstulae simulated (N=1)
Hematology 27 Anemia induced (N=9), purpura induced (N=4), hypercalcemia induced (N=2), hypokalemia induced (N=1), systemic
mastocytosis reported (N=1), acute lymphoblastic leukemia reported (N=1), chronic myeloid leukemia reported (N=1), hemophilia
reported (N=1), epistaxis induced (N=1), abnormal coagulation induced (N=1), signs of deep vein thrombosis simulated (N=2),
sickle cell disease reported (N=3)
HIV and Sexual Health 11 History of HIV reported (N=5), history of AIDS reported (N=3), history of HIV-related Kaposi's sarcoma reported (N=1), history of
AIDS-related disease reported (N=1), history of venereal disease reported (N=1)
Microbiology and Infection 13 Sepsis induced (N=7), septic arthritis induced (N=3), necrotizing fasciitis simulated (N=1)
Neurology 32 Chronic pain reported (N=7), paralysis or weakness simulated (N=4), unconsciousness simulated (N=4), cyclic hypersomnia
simulated (N=1), seizures simulated (N=3), torsion dystonia simulated (N=2), hemifacial spasm simulated (N=1), symptoms of
acute meningitis reported (N=2), migraine reported (N=1), scalp abrasions induced (N=2), signs of baroreﬂex failure induced
(N=1), sciatica and urinary incontinence reported (N=1), blindness simulated (N=1), aphasia simulated (N=1), deterioration of
Parkinson's induced (N=1)
Obstetrics and Gynecology 7 Vaginal bleeding induced (N=5), menorrhagia induced (N=1), vaginal discharge simulated (N=1)
Oncology 12 History of breast cancer reported (N=4), family history of breast cancer reported (N=2), ovarian cancer reported (N=1), cancer of
small intestine reported (N=1), uterine cancer reported (N=1), Hodgkin's disease reported (N=1), adenocarcinoma of urinary
bladder reported (N=1), symptoms of osteogenic carcinoma reported (N=1)
Ophthalmology 18 Keratoconjunctivitis induced (N=6), corneal damage induced (N=4), anterior scleritis induced (N=2), diplopia reported (N=2),
acute endophthalmitis induced (N=1), eyelid swelling induced (N=1), crystalline keratopathy induced (N=1), signs of basal cell
carcinoma induced (N=1)
Oral and Maxillofacial 8 Swelling of mandibular region induced (N=2), abrasion of oral mucosa induced (N=2), gingival ulceration induced (N=1),
progressive facial pain reported (N=1), subluxation of jaw simulated (N=1)
Orthopedics and Trauma 34 Subcutaneous emphysema induced (N=5), chronic wound deterioration induced (N=5), pain induced (N=5), severe trauma
simulated (N=4), severe trauma induced (N=3), subfascial emphysema induced (N=2), joint dislocation simulated (N=2), joint
dislocation induced (N=1), chronic edema induced (N=1), burns induced (N=1), pyoderma gangrenosum induced (N=1), trauma
reported (N=1), thigh abscess induced (N=1), suprapubic ulceration and vesicocutaneous ﬁstula induced (N=1)
Plastic and Reconstructive Surgery 13 Wound deterioration induced following surgery (N=9), skin ulceration induced (N=3), deep muscular abscess induced (N=1)
Pulmonary and Respiratory 33 Asthmatic episodes simulated (N=8), acute respiratory distress simulated (N=3), hemoptysis simulated (N=4), hemoptysis reported
(N=3), cystic ﬁbrosis reported (N=2), pleuritic chest pain reported (N=2), intractable bronchorrhea reported (N=1), severe leg pain
and pulmonary history reported (N=1), asphyxia simulated (N=1), inability to be weaned from ventilator reported (N=1),
pneumothorax induced (N=2), hypoxemia induced (N=1), signs of collagen vascular disorder induced (N=1), inhalational
pulmonary talcosis induced (N=1)
Rheumatology 9 Lobular panniculitis induced (N=2), nodular panniculitis induced (N=1), non-speciﬁc panniculitis induced (N=2), polyarthralgia and
subcutaneous masses induced (N=1), systemic lupus erythematosus reported (N=2), arthritis simulated (N=1),
Urology and Nephrology 30 Severe renal pain reported (N=13), UTI induced (N=5), hematuria simulated (N=3), proteinuria simulated (N=1),
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Presence or history of comorbid psychiatric disorders was assessed
in 170 patients. The most common comorbid psychiatric disorder
found in this subsample was depression, which was identiﬁed in
41.8% of these patients. Other common disorders that were identiﬁed
included personality disorder (16.5%), substance abuse (15.3%), anxiety
(14.7%), functional neurological symptoms (5.3%) and eating disorders
(4.1%). A total of 14.1% of patients reported current suicidal ideation
or a history of suicide attempt(s). Authors reported the absence of co-
morbid psychopathology in 17.1% of the 170 cases.
3.4. Factors leading to diagnosis of FD
In the majority of cases (78%), an unsubstantiated presentation con-
tributed to a diagnosis of FD. Past healthcare service use contributed todiagnosis in 47% of cases, atypical presentation in 40% of cases, treatment
failure in 35% of cases, investigations indicating fabrication in 33% of cases,
patient behavior in 31% of cases, evidence of fabrication in 31% of cases
and information provided by patient in 22% of cases. In two cases, the di-
agnosis wasmade solely on the basis of a spontaneous confession. A full
breakdown of these factors by medical specialty may be found in
Table 5.
A spreadsheet providing a basic description of all studies included in
this review is provided in Section 4 of the supplemental material.
4. Discussion
4.1. Demographic characteristics
The remarkable proportion of patients in our sample reporting an
occupation related to healthcare or the laboratory (57%) supports
Table 4
FD severity by medical specialty
Specialty N False report of
disease/injury
Feigned
disease/injury
Induced
disease/injury
Allergy and Immunology 8 0% 25% 75%
Cardiology 44 61% 16% 23%
Dermatology 43 0% 0% 100%
Endocrinology 59 7% 2% 92%
ENT 11 9% 45% 45%
Gastroenterology 29 10% 17% 72%
Hematology 27 26% 0% 74%
HIV and Sexual Health 11 100% 0% 0%
Microbiology and Infection 13 0% 0% 100%
Neurology 32 31% 56% 13%
Obstetrics and Gynecology 7 0% 29% 71%
Oncology 12 92% 0% 8%
Ophthalmology 18 6% 6% 89%
Oral and Maxillofacial 8 38% 0% 63%
Orthopedics and Trauma 34 3% 15% 82%
Plastic and Reconstructive Surgery 13 0% 0% 100%
Pulmonary and Respiratory 33 27% 58% 15%
Rheumatology 9 11% 22% 67%
Urology and Nephrology 30 27% 50% 23%
Other 14 29% 36% 36%
Median 10.5% 15.5% 69%
IQR 29.25 34.25 64.25
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have worked in these settings [21,63–68]. Krahn et al.'s [42] chart re-
view of 93 FD patients found that a similar proportion (44%) of patients
worked in a healthcare ﬁeld. Of the 122 patients whomade such a claim
in our review, 114were female, supporting Krahn et al.'s [42] identiﬁca-
tion of a subtype of FD consisting of female healthcare professionals.
Overrepresentation of healthcare professionals in our sample may be
due to publication bias, which will be discussed later. Alternatively,
this result may be explained by the appeal of healthcare-related profes-
sions (in particular, nursing) for these patients. A career within a
healthcare service may carry a similar appeal to deceiving clinicians
for individuals predisposed to FD [69]. The “rush” of undergoingmedical
procedures reported in FD [5] may comparable to the “rush” of deliver-
ing them in a professional setting. On balance, our ﬁndings support the
broad recommendation that healthcare professionals should be particu-
larly vigilant for FD in patients who appear to have unusual medical
knowledge or claim to have worked in related occupations [70].Table 5
Factors leading to diagnosis of FD by medical specialty
Specialty N Past healthcare
service use
Information
provided by patient
Atypical
presenta
Allergy and Immunology 8 25% 0% 50%
Cardiology 44 68% 41% 27%
Dermatology 43 23% 5% 70%
Endocrinology 59 29% 12% 31%
ENT 11 73% 27% 82%
Gastroenterology 29 38% 14% 35%
Hematology 27 70% 22% 30%
HIV and Sexual Health 11 82% 46% 18%
Microbiology and Infection 13 54% 8% 15%
Neurology 32 59% 28% 66%
Obstetrics and Gynecology 7 57% 0% 29%
Oncology 12 67% 75% 25%
Ophthalmology 18 44% 6% 50%
Oral and Maxillofacial 8 50% 0% 38%
Orthopedics and Trauma 34 44% 35% 35%
Plastic and Reconstructive Surgery 13 31% 15% 46%
Pulmonary and Respiratory 33 55% 24% 46%
Rheumatology 9 44% 22% 67%
Urology and Nephrology 30 33% 20% 10%
Other 14 50% 36% 43%
Median 50 21 36.5
IQR 30.75 26.75 22.5The mean age of our sample at presentation (34.2 years) corrobo-
rates the results of several case series that were not included in our re-
view [42,71–74]. This ﬁnding supports the understanding held bymany
authors that patients with FD present to healthcare services in early
adult life [11,20,67,75–77]. An exception was noted with patients pre-
senting with dermatological problems: they tended to be older (40.6
years) and included geriatric cases (Table 2). The ﬁnding of a female
majority (66.2%) in our sample may conclude an ongoing confusion in
the professional literature concerning the gender distribution of pa-
tients with FD. Despite several key case series [42,71,74] and reviews
[52,56,57,78] indicating the opposite, numerous authors havemade ref-
erence to amale predominance in cases of FD [54,79]— likely a result of
the inclusion of a statement to this effect in DSM-IV [43] that was sub-
sequently reversed in DSM-IV-TR [80] and abandoned in DSM-5 [1].
The case studies included in this review that were published before
the release of the DSM-IV in 1994 (N=164) did not support such a
statement: 58.1% of patients in this subsample were female. Our total
sample conﬁrms that, overall, patients with FD tend to be female. How-
ever, important gender differences were observed among specialties
(Table 2). For example, patients presenting with HIV-related, sexual
health or neurological problems were predominantly men, and fewer
than 25% of cardiac patients were female.
4.2. Severity of FD
Our review provided an unprecedented opportunity to compare the
different methods employed by patients with FD in a large sample. We
found that 58.7% of patients elected to induce illness or injury in them-
selves instead of attempting only to simulate (19.1%) or falsely report
(22.2%) a medical problem. This preference would suggest that what
has previously been regarded as an “extreme” variant of FD may in
fact be its most common presentation. Patients with FDmust be consid-
ered at signiﬁcant risk of self-injury. This risk should be factored into
any management plan for individuals suspected of medical deception.
Friends, partners and family members should, if possible, be involved
in this process in order to monitor the patient's access to tools (e.g. sur-
gical instruments) and substances (e.g. prescription drugs, poisons) that
may be used to induce injury or illness. Involuntary detentionmay even
be indicated when patients with FD are socially isolated and using
methods of illness induction that are difﬁcult to control. Abuse of insulin
(to induce hypoglycemia) and self-venesection (to induce anemia) are
two such methods that were utilized by a disturbingly high number oftion
Unsubstantiated
presentation
Evidence of
fabrication
Patient
behavior
Investigations
indicating fabrication
Treatment
failure
63% 50% 38% 38% 50%
91% 23% 50% 21% 32%
79% 26% 16% 30% 42%
78% 32% 10% 73% 36%
91% 55% 73% 18% 27%
86% 41% 24% 52% 28%
78% 41% 22% 41% 19%
91% 9% 46% 0% 18%
54% 69% 23% 62% 54%
84% 13% 63% 9% 31%
71% 29% 14% 43% 43%
50% 17% 25% 0% 0%
67% 28% 44% 28% 33%
75% 63% 25% 0% 100%
56% 24% 27% 32% 32%
69% 23% 31% 39% 77%
88% 27% 27% 15% 49%
89% 56% 33% 11% 44%
90% 43% 23% 23% 17%
64% 7% 43% 36% 29%
78 28.5 27 29 32.5
24 25.25 20.75 28.5 20.5
25G.P. Yates, M.D. Feldman / General Hospital Psychiatry 41 (2016) 20–28patients in our sample and led to fatality in a number of cases. Patients
with FDwhoadopt thesemethodsmay present themselves asmedically
knowledgeable, but it is unlikely that they are fully aware of the proba-
ble adverse consequences of their behaviors.
Authors have assumed that patients with FD are intelligent and re-
sourceful [16,63,66,70] and that these qualities are required to success-
fully deceive experienced clinicians [35]. However, these qualities are
not required by patients with FD who induce illness or injury. Self-
induction of illness or injury enables patients to reliably command at-
tention from hospital staff [3] and may reﬂect a need to self-harm [5].
4.3. Psychopathology
Comorbid psychiatric disorders (or their absence) were described in
only 37% of cases (N=170). This ﬁnding may reﬂect the fact that the
majority of the cases included in this reviewwere notwritten bypsychi-
atrists. Nonetheless, some observationsmay bemade. Only 14.1% of pa-
tients were described as suicidal or as having a history of suicide
attempts. It has been assumed previously that FD entails signiﬁcant sui-
cide risk and suicide attempts have been described (see Ref. [11] for a
useful review). In this regard, our ﬁndingsmay provide a degree of reas-
surance. Similarly, no psychotic symptomatology was described in our
sample to conﬁrm an earlier hypothesis that FD is a defense against psy-
chosis [81,82]. A surprisingﬁndingwas the absence of personality disor-
ders in all but a small minority of this subsample. The claim that FD is
strongly associated with personality disorders (in particular, borderline
personality disorder) is widespread in the professional literature
[11,20,21,65,83–85] and has been included in multiple review articles
[33,44]. Even so, the comorbid diagnosis reported most commonly in
our samplewas depression, providing support instead for an association
between FD and mood disturbance [44,86]. However, the relationship
between these two diagnoses is not clear. FD may be truly comorbid
with depression due to shared risk factors for the two disorders,
which include childhood abuse or neglect [87,88], parental failures
[89–92], marital difﬁculties [93], substance abuse [94–96] and stressful
life events [97,98]. Alternatively, FD may be secondary to depression—
for example, as an expression of low self-esteem or a manifestation of
the urge to self-harm, which has been linked to depressive symptoms
[99,100]. In this case, it is plausible that treatment of depressive symp-
toms in cases of FDmay lead to a reduction of factitious illness behavior.
4.4. Presentation of FD
Considerable variation was observed in the number of cases includ-
ed in this review for each medical specialty. This variation may be ex-
plained by differential interest in FD among authors working in
different specialties [52]. For example, the high number of dermatology
cases eligible for this review may be the result of dermatologists' in-
creased awareness of or interest in FD rather than a genuine “prefer-
ence” of patients with FD. The inclusion of ‘dermatitis artefacta’ in the
ICD predates the inclusion of FD by several decades [101,102]. Alterna-
tively, variation among specialties may be explained by the relative dif-
ﬁculty of identifying FDwithin variousmedical specialties. For example,
the preponderance of factitious hypoglycemia in this reviewmay signal
the comparative ease with which insulin abuse can be detected in the
laboratory [58,59]. However, assuming that the distribution of cases
across medical specialties corresponds to some degree to preferences
of patients with FD, our ﬁndings demonstrate the need for health pro-
fessionals working in endocrinology, cardiology and dermatology ser-
vices to be specially watchful for FD.
As expected, patients with FD gravitated toward signs and symp-
toms leading to protocol-driven or “fast-track” admission, such as
retrosternal chest pain. Similarly, patients made good use of widely
available agents to induce serious illness, such as insulin, anticoagulants
or thyroid hormones. This may have contributed to the high number of
patients presenting with dermatological and endocrinologicalproblems. It is clear that patientswith FD are capable of using theirmed-
ical knowledge not only to simulate illness convincingly but also to ﬁnd
the “path of least resistance” to admission. Nevertheless, many patients
were attracted to specialtieswithmore complex disorders and a greater
likelihood of discovery, such as cardiology and neurology. Kanaan and
Wessely (2005) discussed this problem in their own review of neuro-
logical cases of FD, suggesting that the increased difﬁculty of simulating
certain medical problems (due to modern imaging and laboratory in-
vestigations) may in FD be counterbalanced by increased ‘reward’ in
the form of greater attention and sympathy. This suggestion would ex-
plain the relative popularity of oncology and cardiology to patients in
our sample despite the difﬁculty often involved in fabricating cancer
or coronary disease.
However, we might suggest that it is simply the case that patients
with FD are able tomake asmuchuse ofmodern technology tomaintain
their deception as clinicians are to detect it, and for this reason, it is not
as difﬁcult for these patients to fabricate complex medical problems as
we might assume. Numerous authors included in this review discuss
the ease with which their patients were able to use the Internet to re-
search their presentation of choice [103,104], forge medical reports or
referral letters [105,106] and even purchase prescription medications
[107]. The Internet may therefore enable patients with FD to be sufﬁ-
ciently versatile and adaptive in their deception to present tomore chal-
lengingmedical specialists [108]. In any case, our ﬁndings challenge the
notion that the problems presented by FD will be overcome with inno-
vations in health technology.
4.5. Factors leading to diagnosis of FD
As may be expected, a presentation unsubstantiated by objective
clinical evidencewas found to have facilitated discovery of FD in thema-
jority of cases included in this review across all specialties. Our review
therefore supports existing guidelines that caution health professionals
to consider FD early when encountering patients whose complaints ap-
pear unsupported by physical examination, the results of investigations
and so forth [33,44]. However, the variance among medical specialties
that we observed in clinicians' use of other sources of information diag-
nose FD is unaccounted for by these guidelines and contrasts sharply
with several claims made in the published literature. For example, it
has been assumed that dermatologists are able to diagnose FD primarily
on the basis of physical examination because skin lesions produced by
patients with FD are morphologically atypical [109–111] and located
on easily accessible areas of the body [112]. While this clinical picture
facilitated diagnosis in 70% of the dermatological cases of FD that we
reviewed, in a signiﬁcant minority of cases, the appearance of lesions
did not alert dermatologists to the possibility that they were being de-
ceived. Similarly, although it has been argued that patients presenting
with factitious endocrinological illness may be recognized by their sur-
gical history [113], in themajority of cases involving such patients, such
a history was either not described or not regarded as suspicious by en-
docrinologists. Future guidelines for the detection of FD in clinical set-
tings must be data driven and sensitive to the practical realities of
diagnosing the disorder in different medical specialties. This approach
will help to avoid problematic assumptions of the kind discussed
above and to offset the limitations of “one sizeﬁts all” clinical guidelines
for FD. Ourﬁndings, accrued from the largest sample of patientswith FD
analyzed to date and a broad range of medical specialties, provide a ro-
bust starting point for such an approach.
4.6. Limitations
A number of limitations to this reviewmust be acknowledged. First-
ly, although case reports constitute the best source of knowledge cur-
rently available about FD, the sample used in this review is
nonrandom and unlikely to be fully representative. Studies appeared
more likely to be published if they presented an unusual manifestation
26 G.P. Yates, M.D. Feldman / General Hospital Psychiatry 41 (2016) 20–28of FD, a novel technique for detecting FD or an entertaining account. A
culture of “one-upmanship” may therefore have deterred potential au-
thors from submitting cases of FD thatwere less severe or similar to pre-
viously published cases. Publication bias of this kind may also have
accounted for the overrepresentation of healthcare professionals in
our sample. Healthcare professionals are clearly capable of using their
expertise to fabricate medical need more convincingly, as is shown in
several reports included in this review [64,114,115]. It therefore stands
to reason that cases involving healthcare professionals would be over-
represented in a literature biased toward ingenious patients. This publi-
cation bias may be compared to the ‘ﬁle-drawer problem’ described in
metaanalysis [116], although the preponderance of less severe and non-
novel cases of FD included in our sample provides reassurance.
Secondly, it is plausible that our sample contains duplicates, as pa-
tients with FD are typically treated by several clinicians in the course
of their deception—potentially across several regions [117] or countries
[118]— any ofwhommaypublish the case [21]. Cases explicitly describ-
ing a previously reported patient were excluded, but publication of
cases in low-impact journals with a limited readership may have re-
stricted the extent to which authors could be aware that they were de-
scribing the same patient as a previous case report.
Thirdly, because we extracted only basic demographic and clinical
information from our sample, we could not examine the relationship
between the results of this review and patient outcomes — nor could
we relate our data to the etiology of FD. Eastwood and Bisson [57] con-
ducted a similar systematic review of cases (N=316) in order to evalu-
ate management techniques for FD. However, inconsistent reporting of
outcomes in case studies on FD signiﬁcantly limited the extent to which
they were able to use their analysis to make recommendations for the
treatment of the disorder. This would suggest that original research is
required to address these research questions assertively.
Finally, although care was taken to include only cases meeting a
highly conservative interpretation of the DSM-5 criteria for FD [42], it
possible that factors integral to the diagnosis of FD (e.g. absence of ex-
ternal reward)were not considered by authors, asmany healthcare pro-
fessionals do not encounter FD in everyday clinical practice and are
unfamiliarwith its diagnostic criteria [119]. Indeed, themost convincing
patients with FD do not appear to meet diagnostic criteria for the disor-
der at all. Cases of FD reported in the professional literature (and conse-
quently, in this review)may represent only the accounts of the patients
least capable of avoiding detection or the clinicians most capable of de-
tecting them.
5. Conclusion
FD is one of the most challenging disorders in medical experience
but the clinical and demographic proﬁle of the disorder has yet to be
clariﬁed with a sufﬁciently large sample. Accordingly, we conducted a
systematic review of 455 cases of FD in the professional literature, the
largest sample analyzed to date. Our ﬁndings provide several clinical
recommendations (see below) and a strong ﬁrst step toward an
evidence-based approach to detection and treatment of FD.
5.1. Clinical recommendations
• Clinicians should be particularly vigilant for FD in patients who are
female, in early adult life and claiming to have worked in
healthcare or a laboratory
• Although patientswith FDmay appear in any specialist setting, en-
docrinology, cardiology and dermatology services should expect to
encounter more
• FD is associated with low suicide risk, but these patients typically
self-induce illness or injury and should therefore be considered
at high risk of permanent damage, if not fatality
• FD is associated with depressive symptoms more than personality
disorders and may be improved by treatments for depressionAppendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.genhosppsych.2016.05.002.References
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